Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07055516 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
A Phase 2 study of Obesity and Type 2 Diabetes, sponsored by NodThera Limited.
- Active
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
- 11
- Study locations
NCT07055516: Active Phase 2 study of Obesity and Type 2 Diabetes, sponsored by NodThera Limited.
NCT07055516 is a Phase 2 study of Obesity and Type 2 Diabetes that is active but no longer recruiting, run by NodThera Limited. The registered enrollment target is 162 participants, above the 56-participant average among 5 other Obesity and Type 2 Diabetes trials with a reported enrollment target (189% higher). The trial reports 11 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07055516, a Phase 2 study of Obesity and Type 2 Diabetes, is active but no longer recruiting, sponsored by NodThera Limited.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
- 11
- Study locations
Study Summary
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG NT-0796
Study Locations (11)
Florida
- Investigative site - Cooper City
- Investigative Site - Hialeah
- Investigative Site - Jacksonville
- Investigative Site - Miami
- Investigative Site - Port Orange
Arizona
- Investigative site - Mesa
California
- Investigative site - Los Angeles
Louisiana
- Investigative Sites - Marrero
Ohio
- Investigative Site - Columbus
Texas
- Investigative Site - Dallas
Virginia
- Investigative Site - Manassas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2026-03-31 |
| Phase | Phase 2 |
What the registry record for NCT07055516 still lists
NCT07055516 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, above the 56-participant average among 5 other Obesity and Type 2 Diabetes trials with a reported enrollment target (189% higher).
The record links to 1 condition, with Obesity and Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07055516 lists 11 locations in 7 states (Florida, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT07055516 about?
NCT07055516 is a clinical study titled "Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus". A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
What is the current status of trial NCT07055516?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2025-05-08. Estimated completion is 2026-03-31.
What conditions does trial NCT07055516 study?
This clinical trial studies the following conditions: Obesity and Type 2 Diabetes.
What interventions are being tested in trial NCT07055516?
The interventions under investigation include: Placebo (DRUG), NT-0796 (DRUG).
Who is sponsoring clinical trial NCT07055516?
This trial is sponsored by NodThera Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07055516 being conducted?
This trial has 11 study locations across Arizona, California, Florida, Louisiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity and Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls
RECRUITING · NA
-
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
RECRUITING · NA
-
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
RECRUITING · NA
-
Role of KATP Channel Loss in Type 2 Diabetes
RECRUITING · NA
-
Investigating Metabolic and Psychological Adaptations in a Clinical Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI